Predictors of benefits from frontline chemoimmunotherapy in stage IV non-small-cell lung cancer: a meta-analysis by Hazem E. El-Osta, Frank E. Mott, Bryan M. Burt, Daniel Y. Wang, Anita L. Sabichi

Get full text

Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature by Felipe Soto, Luis F. Torre-Sada, Frank E. Mott, Sang T. Kim, Roza Nurieva, Vickie R. Shannon, Saadia A. Faiz, Roberto F. Casal, Mehmet Altan, Julie Lin, Ajay Sheshadri

Get full text

Association of hearing loss and tinnitus symptoms with health‐related quality of life among long‐term oropharyngeal cancer survivors by Puja Aggarwal, Marc‐Elie Nader, Paul W. Gidley, Raj Pratihar, Shirin Jivani, Adam S. Garden, Frank E. Mott, Ryan P. Goepfert, Christopher Wallace Ogboe, Camille Charles, Clifton D. Fuller, Stephen Y. Lai, G. Brandon Gunn, Erich M. Sturgis, Ehab Y. Hanna, Katherine A. Hutcheson, Sanjay Shete

Get full text

Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors by Puja Aggarwal, Katherine A. Hutcheson, Robert Yu, Jian Wang, Clifton D. Fuller, Adam S. Garden, Ryan P. Goepfert, Jillian Rigert, Frank E. Mott, Charles Lu, Stephen Y. Lai, G. Brandon Gunn, Mark S. Chambers, Guojun Li, Chih-Chieh Wu, Ehab Y. Hanna, Erich M. Sturgis, Sanjay Shete

Get full text

Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations by Whitney E. Lewis, PharmD, Lingzhi Hong, MD, PhD, Frank E. Mott, MD, George Simon, MD, Carol C. Wu, MD, Waree Rinsurongkawong, MS, MS, PhD, J. Jack Lee, MS, PhD, Vincent K. Lam, MD, John V. Heymach, MD, PhD, Jianjun Zhang, MD, PhD, Xiuning Le, MD, PhD

Get full text